Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 60760-486 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication named Pregabalin in capsule form with a strength of 200mg. It shows the different quantities that the medication can be bought in and the RX numbers of the capsules. It also displays the manufacturing information and the contact for the company that manages pharmacy programs. The medication should be stored at room temperature, and the instructions state to use as directed.*
The text shows a table indicating the percentage of patients improved based on the dosage of Pregabalin (160 mg) given over a period of 3 days. There is also a mention of improvement in pain from the baseline. However, the table appears incomplete with random numbers and characters that are not clear, making it difficult to draw a meaningful conclusion.*
This is a chart displaying the percent of improvement in pain for patients taking different medications, including Pregatalin and Pregabain, with varying dosages and frequency. There is also a graph showing the percentage of improvement over time.*
This appears to be a table depicting the results of a study evaluating the effectiveness of three different interventions (Fregabalin 100 mg three times a day, Pregataiin 80 mg three times a day, and Placebo) in reducing pain for patients. The table shows the percentage of patients who improved after the interventions, as well as the percent improvement in pain from baseline for each intervention.*
The provided text contains a table with information related to the dosages and efficacy of a product under study. Dosages from 50mg/day to 600mg/day were used, and the efficacy of the product was statistically significant compared to the placebo. No further information is available.*
This appears to be a chart with estimated percentages of subjects without LTR (long-term response) for two different treatments, Progabain and Placebo, over a period of 120 days. The percentage values range from 0% to 100% with 10 day intervals.*
This table shows the percent of subjects who improved from baseline to Week 16 for a study on Pregabalin compared to a placebo. The percent of subjects improved is listed on the left-hand side, and the measurements for improvement are listed on the bottom row. The measurements are in the range of 210 to 280.*
This text appears to be describing a formula for calculating creatinine clearance, a measure of how well a person's kidneys are filtering blood. The formula involves subtracting the patient's age (in years) from 140, then multiplying that result by their weight in kilograms. For female patients, this result is then multiplied by 0.85. Finally, the formula involves multiplying the result of these calculations by the patient's serum creatinine level (in milligrams per deciliter).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.